RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
108 hedge funds and large institutions have $261M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 21 closing their positions.
14% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 21
2% more funds holding
Funds holding: 106 → 108 (+2)
6% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 34
9% less capital invested
Capital invested by funds: $287M → $261M (-$26.4M)
47% less call options, than puts
Call options by funds: $7.53M | Put options by funds: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.29M |
| 2 |
BC
Broadfin Capital
New York
|
+$5.8M |
| 3 |
SHI
SV Health Investors
Boston,
Massachusetts
|
+$5.15M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.86M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$6.65M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4M |
| 3 |
Axa
Paris,
France
|
-$3.7M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.19M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.77M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SO
126
STRS Ohio
Columbus,
Ohio
| – | -$20K | -3,400 | Closed |
|
|
WA
127
WFG Advisors
Dallas,
Texas
| – | -$1K | -145 | Closed |
|
128
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$145 | +25 | +63% |
|
RPTP Hedge Fund Activity: Q4 2015 in Review
108 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2015, worth a combined $261M — down 9.2% from $287M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new RPTP positions and 21 closed out — a net gain of 3 holders — while 36 added to existing stakes and 34 trimmed.
The largest buyer was Millennium Management, adding an estimated $8.29M. The largest seller was Highland Capital Management (Texas), exiting entirely with an estimated $6.65M sold.
- 108 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2015, up from 106 in Q3 2015.
- Funds reported $261M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2015, down 9.2% quarter-over-quarter.
- 24 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2015 and 21 closed out, a net change of +3 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q4 2015 was Millennium Management, an estimated $8.29M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2015 was Highland Capital Management (Texas), an estimated $6.65M sold.
Based on aggregated 13F filings for Q4 2015.